NCT00772161View on ClinicalTrials.gov

Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD)

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

October 31, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
DRUG

Methylphenidate

Comparison of two extended-release formulations of 20mg Methylphenidate in a cross-over design.

Trial Locations (1)

D-79104

University Hospital Freiburg, Dep. for Child & Adolescent Psychiatry, Freiburg im Breisgau

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

University Hospital Freiburg

OTHER

NCT00772161 - Pharmacokinetics of Two Extended-Release Formulations of Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD) | Biotech Hunter | Biotech Hunter